Furthermore, in a randomized, double-blind, placebo-controlled study enrolling 70 patients with AD aged 6 to 12 years, the administration of melatonin (6 mg daily) demonstrated to improve SCORAD ( p = 0.007), objective SCORAD ( p = 0.001), serum total IgE levels ( p = 0.005) and Childrens Sleep Habits Questionnaire scores ( p = 0.006) at 6 weeks (40)
Metabolic improvement and liver regeneration by inhibiting CXXC5 function for non-alcoholic steatohepatitis treatment
Lv H, Zhen C, Liu J, Yang P, Hu L, Shang P
Regulatory Compliance Manufactured under globally compliant quality systems with validated analytical characterisation and stability protocols, supported by complete regulatory documentation